Clinical Trial Update: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intracranially implanted carmustine for newly diagnosed malignant glioma, assessing safety and efficacy. The study includes gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligoastrocytoma
• Anaplastic Oligodendroglioma
• Glioblastoma

Drugs mentioned

• Carmustine (carmustine)

Snippet

Sponsor: Shandong Lanjin Pharmaceuticals Co.,Ltd | Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 3 | Status: UNKNOWN